Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity

2010 
Findings suggest that the efficacy of antibody-based therapy of solid tumors can be improved by engineering changes in the antibody constant region that enhance ADCC.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    50
    References
    20
    Citations
    NaN
    KQI
    []